Japanese drug maker Daichii Sankyo is planning to bring in technical people and expertise to help its Indian arm Ranbaxy comply with USFDA... ...http://www.moneycontrol.com/news/business/daichii-plans-to-bringtechnical-experts-to-help-ranbaxy_1011295.html
extending recent gains triggered by the company receiving the final approval from USFDA to manufacture and market a generic medicine in the United... ...http://www.business-standard.com/article/news-cm/aurobindo-pharma-jumps-almost-30-in-five-sessions-113121900447_1.html
Posted by Equitymaster After opening in the red on Fed's announcement to phase out quantitative easing, Indian share markets continued to trade... ...http://www.equitymaster.com/tm/tm.asp?date=12/19/2013&title=Banking--engineering-top-losers--engineering-top-losers
India's pharmaceutical sector will touch US$ 45 billion by 2020, according to a major study by global management and consulting firm, McKinsey &... ...http://www.ibef.org/industry/pharmaceutical-india.aspx
Merrill Lynch Capital Markets Espana SA SV has reportedly bought 21.40 lakh shares or 0.79% stake of Glenmark Pharmaceuticals through the open... ...http://www.indian-commodity.com/corporate/merrill-lynch-buys-21-40-lakh-shares-of-glenmark-pharmaceuticals-report.aspx
Miocon is pleased to introduce...